1
|
Dong QL and Wang GN: Effect of general
anaesthesia with combination of acupuncture and enflurane applied
in radical operation of laryngocarcinoma. Chin J Integr Med.
12:306–309. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen LW, Wang JL, Zhang LY, Yang SM, Li
CS, Yu N, Zhao W JD, Zhao LD, Li K, Liu MB and Zhai SQ:
Establishment of an animal model of spontaneous cervical lymph node
metastasis of laryngeal squamous cell carcinoma and obtaining
laryngocarcinoma cells with high metastatic potential. Neoplasma.
60:504–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Jiang LY, Lian M, Wang H, Fang JG and Wang
Q: Inhibitory effects of 5-Aza-2′-deoxycytidine and trichostatin A
in combination with p53-expressing adenovirus on human
laryngocarcinoma cells. Chin J Cancer Res. 24:232–237. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Wang XX, Yao XB, Qiang ZS and Zhu HL:
Attenuation of EGFL7 inhibits human laryngocarcinoma cells growth
and invasion. Int J Clin Exp Med. 8:3141–3155. 2015.PubMed/NCBI
|
5
|
Fodor T, Szántó M, Abdul-Rahman O, Nagy L,
Dér Á, Kiss B and Bai P: Combined treatment of MCF-7 cells with
AICAR and methotrexate, arrests cell cycle and reverses warburg
metabolism through AMP-activated protein kinase (AMPK) and FOXO1.
PLoS One. 11:e01502322016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Makarević J, Tsaur I, Juengel E, Borgmann
H, Nelson K, Thomas C, Bartsch G, Haferkamp A and Blaheta RA:
Amygdalin delays cell cycle progression and blocks growth of
prostate cancer cells in vitro. Life Sci. 147:137–142. 2016.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Liu YF, Qu GQ, Lu YM, Kong WM, Liu Y, Chen
WX and Liao XH: Silencing of MAP4K4 by short hairpin RNA suppresses
proliferation, induces G1 cell cycle arrest and induces apoptosis
in gastric cancer cells. Mol Med Rep. 13:41–48. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Liu G, Ren X, Gao C and Zhang W:
Acylglycerol kinase promotes the proliferation and cell cycle
progression of oral squamous cell carcinoma. Mol Med Rep.
12:2225–2230. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Latocha M, Płonka J, Kuśmierz D, Jurzak M,
Polaniak R and Nowosad A: Transcripional activity of genes encoding
MMPs and TIMPs in breast cancer cells treated by genistein and in
normal cancer-associated fibroblasts-in vitro studies. Acta Pol
Pharm. 71:1095–1102. 2014.PubMed/NCBI
|
10
|
Gurgel DC, Valença-Junior JT, Dornelas CA,
Vieira RB, Maia-Filho JT, Lima-Junior RC, Ribeiro RA and Almeida
PR: Immunoexpression of metalloproteinases 2 and 14 and TIMP-2
inhibitor in main types of primary gastric carcinomas and lymph
node metastasis. Pathol Oncol Res. 21:73–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Navarini NF, Araújo VC, Brown AL,
Passador-Santos F, Souza IF, Napimoga MH, Araújo NS and Martinez
EF: The EGF signaling pathway influences cell migration and the
secretion of metalloproteinases by myoepithelial cells in
pleomorphic adenoma. Tumour Biol. 36:205–211. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kang N, Hu G, Wu W, Jiang J and Yang X:
The impact of PDTC on circulating tumor cells of laryngocarcinoma
in nude mice model. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
25:419–422. 2011.(In Chinese). PubMed/NCBI
|
13
|
Gaundar SS and Bendall LJ: The potential
and limitations of p38MAPK as a drug target for the treatment of
hematological malignancies. Curr Drug Targets. 11:823–833. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Noel JK, Crean S, Claflin JE, Ranganathan
G, Linz H and Lahn M: Systematic review to establish the safety
profiles for direct and indirect inhibitors of p38
Mitogen-activated protein kinases for treatment of cancer. A
systematic review of the literature. Med Oncol. 25:323–330. 2008.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhang ZD, Li Y, Fan Q, Zhao B, Tan B and
Zhao XF: Annexin A2 is implicated in multi-drug-resistance in
gastric cancer through p38MAPK and AKT pathway. Neoplasma.
61:627–637. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Park SH, Lee HJ, Ryu J, Son KH, Kwon SY,
Lee SK, Kim YS, Hong JH, Seok JH and Lee CJ: Effects of
ophiopogonin D and spicatoside A derived from Liriope Tuber on
secretion and production of mucin from airway epithelial cells.
Phytomedicine. 21:172–176. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ishibashi H, Mochidome T, Okai J, Ichiki
H, Shimada H and Takahama K: Activation of potassium conductance by
ophiopogonin-D in acutely dissociated rat paratracheal neurones. Br
J Pharmacol. 132:461–466. 2001. View Article : Google Scholar : PubMed/NCBI
|
18
|
Zang QQ, Zhang L, Gao N and Huang C:
Ophiopogonin D inhibits cell proliferation, causes cell cycle
arrest at G2/M, and induces apoptosis in human breast carcinoma
MCF-7 cells. J Integr Med. 14:51–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Qian J, Jiang F, Wang B, Yu Y, Zhang X and
Yin Z: Ophiopogonin D prevents H2O2-induced injury in primary human
umbilical vein endothelial cells. J Ethnopharmacol. 128:438–445.
2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Li X, Shen Y, Di B, Li J, Geng J, Lu X and
He Z: Biological and clinical significance of p75NTR expression in
laryngeal squamous epithelia and laryngocarcinoma. Acta
Otolaryngol. 132:314–324. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Lohberger B, Leithner A, Stuendl N,
Kaltenegger H, Kullich W and Steinecker-Frohnwieser B: Diacerein
retards cell growth of chondrosarcoma cells at the G2/M cell cycle
checkpoint via cyclin B1/CDK1 and CDK2 downregulation. BMC Cancer.
15:8912015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Song Y, Zhao C, Dong L, Fu M, Xue L, Huang
Z, Tong T, Zhou Z, Chen A, Yang Z, et al: Overexpression of cyclin
B1 in human esophageal squamous cell carcinoma cells induces tumor
cell invasive growth and metastasis. Carcinogenesis. 29:307–315.
2008. View Article : Google Scholar : PubMed/NCBI
|
23
|
Dao T, Korontsvit T, Zakhaleva V, Haro K,
Packin J and Scheinberg DA: Identification of a human cyclin
D1-derived peptide that induces human cytotoxic CD4 T cells. PLoS
One. 4:e67302009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Luukkaa H, Klemi P, Leivo I, Mäkitie AA,
Irish J, Gilbert R, Perez-Ordonez B, Hirsimäki P, Vahlberg T,
Kivisaari A, et al: Expression of matrix metalloproteinase-1, −7,
−9, −13, Ki-67, and HER-2 in epithelial-myoepithelial salivary
gland cancer. Head Neck. 32:1019–1027. 2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Munaut C, Noël A, Hougrand O, Foidart JM,
Boniver J and Deprez M: Vascular endothelial growth factor
expression correlates with matrix metalloproteinases MT1-MMP, MMP-2
and MMP-9 in human glioblastomas. Int J Cancer. 106:848–855. 2003.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhang Y, Han Y, Zhai K, Sun M, Liu J, Yu B
and Kou J: Ophiopogonin-D suppresses MDA-MB-435 cell adhesion and
invasion by inhibiting matrix metalloproteinase-9. Mol Med Rep.
12:1493–1498. 2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Singh P, Sarkar S, Umar S, Rengifo-Cam W,
Singh AP and Wood TG: Insulin-like growth factors are more
effective than progastrin in reversing proapoptotic effects of
curcumin: Critical role of p38MAPK. Am J Physiol Gastrointest Liver
Physiol. 298:G551–G562. 2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Estrella VC, Eder AM, Liu S, Pustilnik TB,
Tabassam FH, Claret FX, Gallick GE, Mills GB and Wiener JR:
Lysophosphatidic acid induction of urokinase plasminogen activator
secretion requires activation of the p38MAPK pathway. Int J Oncol.
31:441–449. 2007.PubMed/NCBI
|